Your article was successfully shared with the contacts you provided.
The defined-benefit (DB) pension plan is beginning to play a bigger role in liquidity forecasting and planning at $67 billion Pfizer. The financial crisis and slide in interest rates created volatility in the funded status of many DB plans. Pfizer’s plan was fully funded in 2006, but fell to 81% funded by 2011. While the company has made cash contributions to the plan to shore up the assets and while asset valuations have rebounded, these pluses have largely been offset by a sharp rise in pension liabilities resulting from lower discount rates.
Pfizer recently decided to move from a DB plan to an enhanced savings plan, which will be completed by 2018. Until then, it needed a sophisticated, reliable model to support planning for pension liquidity and its earnings-per-share impact. The pension world is full of predictive models, but Pfizer wanted something more integrated and customized, so it built its own better mousetrap at a cost of over 500 man-hours.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.